Japan turns to Israeli tech to treat radiation disease

Japan’s Fukushima Medical University and Israel’s Pluristem Therapeutics are to develop Pluristem’s PLX-R18 cells to treat acute radiation syndrome (ARS). Radiation continues to spread following the Fukushima nuclear plant disaster.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *